journal article·2026-06-01Open access

Fabricating engineered tissues with spatially varied microenvironments via embedded 3D printing in a cell-dense suspension

Min Ye, Jie Gao, Zhiyuan Zheng, Di Xin, Zhe Zhang, Shilu Zhu, Qingdong Zhang, Yang Zhang, Liang Xu, Shuwei Shen, Mingzhai Sun, Ronald X Xu

Abstract

Abstract The long-term goal of bioengineered tissues is to achieve precise cell type distribution, physiological cell density, perfusable vascular channels, and mature functionality. However, fabricating engineered tissue with the microenvironmental features of organs with physiological cell density remains a significant challenge in this field. To address this, several key obstacles must be overcome. First, vascularization is indispensable for engineered tissues; however, disturbances may occur when introducing vascular channels within pre-fabricated tissues. Second, maintaining fabrication precision becomes increasingly difficult during high-cell-density embedded printing. Third, the suspension bath used for embedded printing often fails to provide a suitable growth environment. Herein, we modified the rheological properties of the bioactive hydrogel by incorporating a thixotropic laponite nanoclay (LPN) and demonstrated that an optimized ratio of collagen methacrylate (ColMA) to LPN forms a self-healing suspension bath, which is enhanced by hydrogen bonding interactions and is capable of in situ crosslinking. This printing strategy was generalized as the embedded 3D printing in cell-dense suspension (EPICS). The self-healing properties of the EPICS remain unaffected even when encapsulating a near-physiological cell density of 10 8 cells·mL −1 , and it provides precise control of the printing resolution from 1 mm to 100 µm. Compared with the model containing 10 6 cells·mL −1 , the use of EPICS could create a robust hepatic model with mature liver markers and reduced apoptosis gene expression. Moreover, EPICS can efficiently fabricate spatially controlled perfusable channels, thereby mimicking the spatially varied microenvironments of hepatocellular carcinoma, highlighting its broad applications in therapeutics involving tissue and organ constructs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (60)

Show source-provided references
1. Tissue engineering and regenerative medicine: history, progress, and challenges10.1146/annurev-chembioeng-061010-114257 ↗
2. Tissue engineering: still facing a long way ahead10.1016/j.jconrel.2018.04.024 ↗
3. Bioprinting functional tissues10.1016/j.actbio.2019.01.009 ↗
4. Engineering vascularized tissue10.1038/nbt0705-821 ↗
5. Engineering vascularized skeletal muscle tissue10.1038/nbt1109 ↗
6. Retrospective: advances and opportunities of 3D bioprinting in China over three decades10.1016/j.amf.2024.200157 ↗
7. Recent advances on bioengineering approaches for fabrication of functional engineered cardiac pumps: a review10.1016/j.biomaterials.2021.121298 ↗
8. Bioprinted research models of urological malignancy10.1002/EXP.20230126 ↗
9. High cell density and high-resolution 3D bioprinting for fabricating vascularized tissues10.1126/sciadv.ade7923 ↗
10. Advances in cell-rich inks for biofabricating living architectures10.1002/adma.202313776 ↗
11. 3D printing of physical organ models: recent developments and challenges10.1002/advs.202101394 ↗
12. Printability and shape fidelity of bioinks in 3D bioprinting10.1021/acs.chemrev.0c00084 ↗
13. High-resolution patterned cellular constructs by droplet-based 3D printing10.1038/s41598-017-06358-x ↗
14. Effects of dispensing pressure and nozzle diameter on cell survival from solid freeform fabrication-based direct cell writing10.1089/ten.a.2007.0004 ↗
15. 3D bioprinting vascular networks in suspension baths10.1016/j.apmt.2022.101729 ↗
16. 3D printing in suspension baths: keeping the promises of bioprinting afloat10.1016/j.tibtech.2019.12.020 ↗
17. Expanding embedded 3D bioprinting capability for engineering complex organs with freeform vascular networks10.1002/adma.202205082 ↗
18. 3D bioprinting of collagen to rebuild components of the human heart10.1126/science.aav9051 ↗
19. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels10.1126/sciadv.aaw2459 ↗
20. A microgel-hydrogel hybrid for functional compensation and mechanical stability in 3D printed cell-dense vascularized liver tissue10.1002/adma.202413940 ↗
21. Construction of complex three-dimensional vascularized liver tissue model in vitro based on a biphasic cell-laden embedding medium10.1088/2631-7990/ada836 ↗
22. Collagen bioinks for bioprinting: a systematic review of hydrogel properties, bioprinting parameters, protocols, and bioprinted structure characteristics10.3390/biomedicines9091137 ↗
23. A practical guide to hydrogels for cell culture10.1038/nmeth.3839 ↗
24. Bioactive scaffolds for tissue engineering: a review of decellularized extracellular matrix applications and innovations10.1002/EXP.20230078 ↗
25. Laponite-based nanocomposite hydrogels for drug delivery applications10.3390/ph16060821 ↗
26. Smart shear-thinning hydrogels as injectable drug delivery systems10.3390/polym10121317 ↗
27. Nanoengineered osteoinductive bioink for 3D bioprinting bone tissue10.1021/acsami.9b19037 ↗
28. Photocross-linkable methacrylated polypeptides and polysaccharides for casting, injecting, and 3D fabrication10.1021/acs.biomac.0c01322 ↗
29. Proposal to assess printability of bioinks for extrusion-based bioprinting and evaluation of rheological properties governing bioprintability10.1088/1758-5090/aa8dd8 ↗
30. Embedded extrusion printing in yield-stress-fluid baths10.1016/j.matt.2022.09.003 ↗
31. Simulated filament shapes in embedded 3D printing10.1039/D1SM00731A ↗
32. Flow behavior prior to crosslinking: the need for precursor rheology for placement of hydrogels in medical applications and for 3D bioprinting10.1016/j.progpolymsci.2019.01.003 ↗
33. Bioactive glass functionalized chondroitin sulfate hydrogel with proangiogenic properties10.1002/bip.23328 ↗
34. Effect of bioink properties on printability and cell viability for 3D bioplotting of embryonic stem cells10.1088/1758-5090/8/3/035020 ↗
35. Phototethering of collagen onto polyetheretherketone surfaces to enhance osteoblastic and endothelial performance10.1002/mabi.202200115 ↗
36. Development of photo-crosslinkable collagen hydrogel building blocks for vascular tissue engineering applications: a superior alternative to methacrylated gelatin?10.1016/j.msec.2021.112460 ↗
37. Macroporous methacrylated hyaluronic acid hydrogel with different pore sizes forin vitroandin vivoevaluation of vascularization10.1088/1748-605X/ac494b ↗
38. Repair of liver mediated by adult mouse liver neuro-glia antigen 2-positive progenitor cell transplantation in a mouse model of cirrhosis10.1038/srep21783 ↗
39. Cell fate decisions of human iPSC-derived bipotential hepatoblasts depend on cell density10.1371/journal.pone.0200416 ↗
40. Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2)10.1016/j.taap.2008.10.005 ↗
41. Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta10.1016/j.placenta.2006.03.009 ↗
42. MKI67 as a potential diagnostic biomarker in pulmonary hypertension10.3389/fped.2022.1016889 ↗
43. Ki-67 gene expression10.1038/s41418-021-00823-x ↗
44. TGF-β1 reduces the differentiation of porcine IgA-producing plasma cells by inducing IgM(+) B cells apoptosis via Bax/Bcl2-Caspase3 pathway10.1096/fj.202300824RR ↗
45. Upregulation of Bcl2 inhibits apoptosis-driven BAX insertion but favors BAX relocalization in mitochondria10.1016/j.febslet.2010.07.002 ↗
46. Targeting apoptotic pathways for cancer therapy10.1172/JCI179570 ↗
47. Cancer. p53, guardian of the genome10.1038/358015a0 ↗
48. p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment10.1038/sj.onc.1207657 ↗
49. Liver function tests and their interpretation10.1007/s12098-007-0118-7 ↗
50. Real-time monitoring of liver fibrosis through embedded sensors in a microphysiological system10.1186/s40580-021-00253-y ↗
51. HIF1A overexpression using cell-penetrating DNA-binding protein induces angiogenesis in vitro and in vivo10.1007/s11010-017-3098-6 ↗
52. Hypoxia-induced angiogenesis during carcinogenesis10.5483/bmbrep.2003.36.1.120 ↗
53. Regulation of angiogenesis by oxygen and metabolism10.1016/j.devcel.2009.01.003 ↗
54. Receptor tyrosine kinase-mediated angiogenesis10.1101/cshperspect.a009183 ↗
55. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system10.1038/nrm2639 ↗
56. The angiopoietin-Tie2 signaling axis in systemic inflammation10.1681/ASN.2017010069 ↗
57. Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems10.1042/CS20160129 ↗
58. Regulation of angiogenesis by hypoxia: role of the HIF system10.1038/nm0603-677 ↗
59. Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors10.3858/emm.2009.41.12.103 ↗
60. Physiological signatures of dual embryonic origins in mouse skull vault10.1159/000484496 ↗